Lion Street Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$801K Sell
6,983
-1,676
-19% -$341K 0.28% 75
2025
Q2
$1.61M Buy
8,659
+1,052
+14% +$196K 0.49% 41
2025
Q1
$1.59M Sell
7,607
-184
-2% -$35.8K 0.51% 39
2024
Q4
$1.38M Buy
7,791
+1,914
+33% +$352K 0.44% 44
2024
Q3
$1.16M Buy
5,877
+9
+0.2% +$1.68K 0.4% 50
2024
Q2
$1.01M Sell
5,868
-62
-1% -$10.3K 0.37% 54
2024
Q1
$919K Hold
5,930
0.38% 54
2023
Q4
$919K Sell
5,930
-5,007
-46% -$730K 0.38% 54
2023
Q3
$1.63M Buy
10,937
+3,798
+53% +$558K 0.53% 29
2023
Q2
$819K Sell
7,139
-3,172
-31% -$465K 0.28% 73
2023
Q1
$1.64M Buy
10,311
+5,547
+116% +$848K 0.51% 26
2022
Q4
$546K Sell
4,764
-3,639
-43% -$558K 0.29% 56
2022
Q3
$1.13M Buy
8,403
+3,639
+76% +$522K 0.56% 15
2022
Q2
$542K Buy
4,764
+53
+1% +$8.1K 0.28% 58
2022
Q1
$760K Sell
4,711
-50
-1% -$7.26K 0.39% 36
2021
Q4
$648K Sell
4,761
-490
-9% -$57.9K 0.32% 48
2021
Q3
$567K Buy
+5,251
New +$600K 0.31% 54
2020
Q2
Sell
-381
Closed -$29K 28
2020
Q1
$29K Buy
+381
New +$32.5K 0.16% 76

Other funds holding ABBV